Millennium Management LLC lowered its position in shares of Exantas Capital Corp (NYSE:XAN) by 8.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 325,103 shares of the company’s stock after selling 30,115 shares during the period. Millennium Management LLC owned approximately 1.03% of Exantas Capital worth $3,258,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently made changes to their positions in XAN. Bayview Asset Management LLC bought a new stake in shares of Exantas Capital during the fourth quarter valued at approximately $8,482,000. Mackenzie Financial Corp increased its position in shares of Exantas Capital by 454.1% during the fourth quarter. Mackenzie Financial Corp now owns 401,654 shares of the company’s stock valued at $4,025,000 after acquiring an additional 329,165 shares in the last quarter. Vanguard Group Inc increased its position in shares of Exantas Capital by 15.3% during the third quarter. Vanguard Group Inc now owns 1,899,504 shares of the company’s stock valued at $20,857,000 after acquiring an additional 252,230 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Exantas Capital by 15.3% during the third quarter. Vanguard Group Inc. now owns 1,899,504 shares of the company’s stock valued at $20,857,000 after acquiring an additional 252,230 shares in the last quarter. Finally, BlackRock Inc. increased its position in shares of Exantas Capital by 7.3% during the third quarter. BlackRock Inc. now owns 3,077,344 shares of the company’s stock valued at $33,789,000 after acquiring an additional 208,387 shares in the last quarter. 66.66% of the stock is owned by institutional investors.
NYSE:XAN opened at $10.69 on Friday. The company has a quick ratio of 132.44, a current ratio of 132.44 and a debt-to-equity ratio of 2.81. Exantas Capital Corp has a 12 month low of $9.40 and a 12 month high of $12.09. The company has a market capitalization of $340.51 million, a price-to-earnings ratio of 15.06 and a beta of 0.80.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 7.48%. The ex-dividend date is Thursday, March 28th. This is an increase from Exantas Capital’s previous quarterly dividend of $0.18. Exantas Capital’s payout ratio is 112.68%.
Several equities research analysts recently weighed in on XAN shares. ValuEngine downgraded shares of Exantas Capital from a “buy” rating to a “hold” rating in a research report on Wednesday, January 2nd. Zacks Investment Research downgraded shares of Exantas Capital from a “hold” rating to a “sell” rating in a research report on Saturday, March 9th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $12.63.
About Exantas Capital
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments.
See Also: Conference Calls
Want to see what other hedge funds are holding XAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exantas Capital Corp (NYSE:XAN).
Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.